Viewing Study NCT02125318

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:31 AM
Ignite Modification Date: 2026-03-01 @ 9:31 PM
Study NCT ID: NCT02125318
Status: COMPLETED
Last Update Posted: 2017-02-27
First Post: 2014-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders
Sponsor: Galena Biopharma, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thrombocytosis View
None Myeloproliferative Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None myeloproliferative neoplasm View
None chronic myelogenous leukemia View
None polycythemia vera View
None primary myelofibrosis View
None essential thrombocythemia View
None anagrelide View
None thrombocytosis View
None GALE-401 View